美国AI医疗临床对话纪录平台Abridge近日宣布，成功完成1.5亿美元的C轮融资，投后估值达到8.5亿美元。本次融资由Lightspeed和Redpoint Ventures共同领投，Mass General Brigham AIDIF、Kaiser Permanente Ventures以及Bessemer Venture Partners和CVS Health Ventures等现有投资者参与跟投。
Abridge利用人工智能技术，帮助医生将患者检查的录音自动转换为医疗记录。截至目前，已有超过10000名临床医生签约使用其软件。这一轮融资的成功，不仅体现了投资者对Abridge技术实力和市场潜力的认可，也预示着AI在医疗领域的应用将进一步深化和拓展。
英文标题：Abridge, an AI-powered Clinical Dialogue Recording Platform, Raises $150 Million in Series C Funding
英文关键词：AI healthcare, clinical dialogue, funding
英文新闻内容：
Abridge, a leading AI-powered clinical dialogue recording platform, has announced the successful completion of a $150 million Series C funding round, bringing its post-money valuation to $850 million. The round was co-led by Lightspeed and Redpoint Ventures, with participation from existing investors including Mass General Brigham AIDIF, Kaiser Permanente Ventures, Bessemer Venture Partners, and CVS Health Ventures.
Abridge uses advanced AI technology to automatically transcribe patient examination recordings into medical records, significantly reducing the administrative burden for healthcare providers. To date, the company has signed contracts with over 10,000 clinicians, showcasing the growing demand for AI solutions in healthcare.
This funding round highlights investor confidence in Abridge’s technology and market potential, signaling a continued expansion of AI applications in the healthcare industry.
【来源】https://www.forbes.com/sites/katiejennings/2024/02/23/abridge-raises-150-million-to-make-ai-medical-scribes-even-smarter/
Views: 1